QSC not done by a long shot... as long as volume pours in... it goes North IMO.
Shares
69.21 m
EPS (TTM)
-0.16
Avg Vol (3m): 737,364
Today'sVolume
11,070,100
Market Cap: 314.89M
Review the earnings in the latest 10Q. A drug already in market is awaiting approval for another indication (disease state). Approval would broaden the potential market for use of the drug.... and thus more profit for QSC.
Results of Operations
Three months ended September 30, 2007 compared to the three months ended September 30, 2006:
Total Net Product Sales
Three Months Ended
September 30, %
2007 2006 Increase Change
(in $000’s)
Net product sales
$ 14,809 $ 4,045 $ 10,764 266 %
Also, very few small pharma companies with profitable drugs in the market are not owned by a larger parent company. That is what makes QSC unique. I doubt that they will stay under the radar long. One of the big boys may buy them out soon enough... could explain the volume IMO.
Just opinion... just thinking out loud.
